Cardio Diagnostics Stock Jumps as Tiny Heart-Test Firm Heads Into June Benefits Push
Cardio Diagnostics shares climbed 6.6% to $2.27 Tuesday, after a 12.7% gain Monday, as traders focused on its June push to sell cardiovascular tests to employers and health-plan buyers. The company reported $2,680 in first-quarter revenue and a $1.79 million net loss. Market value stands at $6.45 million. Cardio recently raised $18.75 million through share sales.